Pharmaceutical spend continues to be a main cost driver in the health care system, while additional governmental regulations challenge payers and providers. Despite factors in the marketplace that are out of our control, we are proud to have delivered a single-digit drug trend rate to our clients in 2015, based on total cost.
Learn more about all of the efforts Navitus has in place today to counter drug trend.
Sagent Pharmaceuticals has voluntarily recalled Oxacillin for Injection, USP, 10g, due to possible particulate matter in the vials.
Teva Pharmaceuticals announced a voluntary recall of seven lots of amikacin sulfate injection USP, 500 mg/2mL (250 mg/mL) and 1 gram/4mL (250 mg/mL). The vials may contain glass.
Contact Us | Careers | MedicareRx (PDP) | BadgerRx Gold | Navi-Gate Rx | Site Map | Confidentiality Statement | Vendor/FDR | Download Adobe Reader